Oncology

Latina & Plankstadt

In principle all the organs of the human body may be attacked by malignant tumours. The body’s cells may deviate in a diseased manner from their genetically-determined lifecycles.
Oncology concerns all forms of the pathophysiology of cells and illnesses that are caused by uncontrolled cell growth.


What these illnesses have in common is that the genetically regulated equilibrium of cell growth and division and cell death (apoptosis) is disturbed.
The body’s cells growing and dividing out of control can supplant or destroy healthy tissue. The spread of cells growing and dividing out of control in the body (metastasis) and attacking other organs and tissues and the consequent failure of regulated organ functions are characteristic of cancer.

In Western industrial countries, cancer is the second most common cause of death after cardiovascular diseases.

The bases of treatment of cancer are surgical measures and various methods of radiology.

In addition, depending on the type, cancers can be treated medically with cytostatics, antihormones, blood vessel formation growth inhibitors or immunotherapy. In many cases by the combination of such medicines.

There is also palliative medical treatment for the improvement of the quality of life of cancer patients. What matters here in medicinal terms is attention to the treatment of pain and relief from the side-effects of other treatment processes, which are expressed mainly in feeling very ill and in being sick.

Pharmaceutical substances and medicines for oncology are manufactured by Corden Pharma Latina SpA and Corden Pharma Plankstadt GmbH.

Cytostatic substances for the manufacture of parenteral and oral formulations are produced by Corden Pharma at the Latina site. Here all the conditions are right for handling such highly potent substances. At the Plankstadt site Corden Pharma has the expertise available to formulate solid forms of highly potent drugs. One focus here is on hormones and hormone blockers.